Jim Tananbaum Play’s A Pivotal Role In Helping Mindstrong Health To Raise $14 Million

Recently, Optum Ventures, Foresite Capital, One Mind Brain Health Impact Fund and ARCH Venture Partners played a pivotal role in raising $14 million for Mindstrong Health in their Series-A Funding. Paul Dagum is the the CEO and Founder of Mindstrong Health, a startup that uses smartphones to diagnose and treat neuropsychiatric disorders. Paul contends that the success of modern medicine is anchored on objective measurement. However, tracking of mental health is subject to clinical environment reports.

Paul went on to state that in order to enhance the outcomes of individuals having mental disorders, there would be the need to use the objective measures available for other diseases such as heart diseases and diabetes. The executive concluded by saying that Mindstrong’s technology of delivering objective measures of behavior and cognition is unrivaled.

Over the years, Mindstrong has been able to develop a platform that measures brain function by taking cognizance of patient’s typing and scrolling patterns on a smartphone. This platform takes account of cognition and mood biomarkers that include processing function, memory and speed. Jim Tananbaum, the chief executive officer of Foresite Capital posited that the founding team of Mindstrong Health has a broad understanding of the various challenges that affect how the medical community caters for patients having cognitive health disorders. This information was originally mentioned on Patient Daily as outlined in this link http://patientdaily.com/stories/511131545-startup-health-tech-firm-mindstrong-health-secures-14-million-in-funding

About Jim Tananbaum

Jim is the founder of Foresite Capital. The company has an asset base of $1.1 billion. He has vast experience in building and investing in successful healthcare companies. Jim is credited for founding two healthcare investment companies and two pharmaceutical corporations. The graduate of Harvard Medical School is the founder of GelTex Pharmaceuticals. Under his leadership, the company brought two successful drugs to the market at a total cost of less than $ 80 million. Today, these drugs are generating $ 1 billion in revenues.

Tananbaum is the founder of Theravance. Together with Theravance Biopharma, Theravance’s spin-off, the two corporation’s market capitalization is $2.75 billion. Earlier in his career, Jim Tananbaum served as a founding partner of a renowned corporation, Prospect Venture Partners II and III. In addition, Jim is affiliated with the success of different companies, including Jazz Pharmaceuticals, Amira Pharmaceuticals, Healtheon and Amerigroup. Tananbaum is a graduate of Yale, Harvard Business School and Massachusetts Institute of Technology.

Follow Foresite Capital on twitter.

Avi Weisfogel Develops New Treatment Modalities for Sleep Apnea

Many people do not fully appreciate how deadly the disease sleep apnea actually is. Being strongly associated with almost every major cause of death in the United States, sleep apnea is both underdiagnosed and undertreated. Some studies have revealed that as many as 90 percent of people suffering from the disease have no idea that they have it. This is a medical catastrophe, causing the state of the general health in the United States to be significantly lower than it would be if the disease was properly treated and recognized in its earliest stages.

Avi Weisfogel is one of New Jersey’s most successful dentists. After graduating with a M.D. in dentistry from the New York University School of Dentistry, he founded his own dental practice, Old Bridge Dental. It quickly grew to become one of the most respected dental practices in Central New Jersey. But Dr. Weisfogel always sought to create more value for his patients. He believed that dentists were in a unique position to identify and treat many diseases of the head neck and mouth area that were otherwise unrecognized and Avi on Facebook.

Dr. Weisfogel had long understood that many patients saw their dentists far more frequently than their general practitioners. While it is very easy to postpone a yearly physical, the reasons that people often go to see their dentists are much more urgent. Postponing something like an abscessed third molar is impossible, even for those with the highest pain thresholds. Even conditions such as cavities or chipped front teeth are simply impossible to ignore. For this reason, many people end up seeing their dentists many times over the course of 10 years. The same people, very frequently, may not see their general practitioner even once and learn more about Avi Weisfogel.

This gives dentists a unique ability to be able to recognize and treat many diseases in the earliest stages, when they are most likely to be effectively treated. Dr. Weisfogel understood this. He created Dental Sleep Masters in order to train dentists how do identify and treat sleep apnea.

Today, Dental Sleep Masters has trained thousands of dentists in the treatment modalities of sleep apnea, saving the lives of thousands of patients.

More visit: https://www.crunchbase.com/person/avi-weisfogel#/entity